Kyle Malady
EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ)
Kyle Malady has filed 194 insider reports with the SEC since January 2021, as EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ) and director at Dexcom Inc (DXCM). In the last 12 months Kyle Malady sold $530K of stock on the open market. The latest filing, on November 20, 2026, reports grant or award at Verizon Communications Inc (VZ).
- Filings
- 194
- Companies
- 2
- Bought on market
- None
- Sold on market
- $7.4M
Companies where Kyle Malady is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| EVP and Group CEO-VZ Business | 95,566 | $7.34M | $46.48 | Nov 20, 2026 | |||
| Director | 28,242 | $53.9K | $79.32 | Jun 1, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 19, 2026VZEVP and Group CEO-VZ Business Kyle Malady was granted 133 units of Phantom StockForm 4Grant or award
- Nov 17, 2026-$50.7KVZEVP and Group CEO-VZ Business Kyle Malady sold $50,666 worth of shares (1,100 units at $46.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 95,566 unitsForm 4Open-market sale10b5-1 plan
- Nov 10, 2026-$50.7KVZEVP and Group CEO-VZ Business Malady Kyle sold $50,721 worth of shares (1,100 units at $46.11) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 96,666 unitsForm 4Open-market sale10b5-1 plan
- Nov 5, 2026VZEVP and Group CEO-VZ Business Malady Kyle was granted 132 units of Phantom StockForm 4Grant or award
- Nov 3, 2026-$49.3KVZEVP and Group CEO-VZ Business Malady Kyle sold $49,269 worth of shares (1,100 units at $44.79) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 97,766 unitsForm 4Open-market sale10b5-1 plan
- Sep 29, 2026-$51KVZEVP and Group CEO-VZ Business Malady Kyle sold $51,040 worth of shares (1,100 units at $46.40) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 103,266 unitsForm 4Open-market sale10b5-1 plan
- Sep 24, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 22, 2026-$52.4KVZEVP and Group CEO-VZ Business Malady Kyle sold $52,415 worth of shares (1,100 units at $47.65) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 104,366 unitsForm 4Open-market sale10b5-1 plan
- Sep 15, 2026-$56.3KVZEVP and Group CEO-VZ Business Malady Kyle sold $56,309 worth of shares (1,100 units at $51.19) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 105,466 unitsForm 4Open-market sale10b5-1 plan
- Sep 10, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 8, 2026-$55KVZEVP and Group CEO-VZ Business Malady Kyle sold $54,978 worth of shares (1,100 units at $49.98) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 106,566 unitsForm 4Open-market sale10b5-1 plan
- Sep 1, 2026-$55.6KVZEVP and Group CEO-VZ Business Malady Kyle sold $55,550 worth of shares (1,100 units at $50.50) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 107,666 unitsForm 4Open-market sale10b5-1 plan
- Aug 27, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Aug 25, 2026-$55.1KVZEVP and Group CEO-VZ Business Malady Kyle sold $55,066 worth of shares (1,100 units at $50.06) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 108,766 unitsForm 4Open-market sale10b5-1 plan
- Aug 18, 2026-$53.5KVZEVP and Group CEO-VZ Business Malady Kyle sold $53,548 worth of shares (1,100 units at $48.68) as part of a pre-agreed trading plan, decreasing direct ownership by 0.99% to 109,866 unitsForm 4Open-market sale10b5-1 plan
- Jul 30, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 16, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 1, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 17, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 4, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- May 28, 2026DXCMDirector Malady Kyle was granted 5,575 shares, increasing direct ownership by 25% to 28,242 unitsForm 4Grant or award
- May 21, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- May 7, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Apr 23, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Apr 9, 2026VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 1, 2026VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 26, 2026VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 12, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Feb 27, 2026VZEVP and Group CEO-VZ Business Malady Kyle covered exercise/tax liability with 50,708 shares and converted options into 100,287 shares, increasing direct ownership by 81% to 110,966 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 26, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Feb 12, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Feb 11, 2026VZEVP and Group CEO-VZ Business Malady Kyle was granted 119,409 shares and covered exercise/tax liability with 58,030 shares, increasing direct ownership by 767,238% to 61,387 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 4, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jan 29, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jan 15, 2026VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Dec 31, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Dec 18, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Dec 4, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Nov 20, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Nov 6, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Oct 23, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Oct 9, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 25, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 11, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 5, 2025-$53.9KDXCMDirector Malady Kyle sold $53,934 worth of shares (667 units at $80.86), decreasing direct ownership by 3% to 22,667 unitsForm 4Open-market sale10b5-1 plan
- Aug 28, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Aug 14, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 31, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 17, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 2, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 18, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 5, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- May 22, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- May 8, 2025DXCMDirector Malady Kyle was granted 5,192 shares, increasing direct ownership by 29% to 23,334 unitsForm 4Grant or award
- May 8, 2025-$438KVZEVP and Group CEO-VZ Business Malady Kyle sold $438,101 worth of shares (10,000 units at $43.81), decreasing direct ownership by 100% to 8 unitsForm 4Grant or awardOpen-market sale
- May 7, 2025-$397KVZEVP and Group CEO-VZ Business Malady Kyle sold $396,900 worth of shares (9,000 units at $44.10), decreasing direct ownership by 47% to 10,008 unitsForm 4Open-market sale
- Apr 30, 2025-$329KVZEVP and Group CEO-VZ Business Malady Kyle sold $329,062 worth of shares (7,500 units at $43.88), decreasing direct ownership by 28% to 19,008 unitsForm 4Open-market sale
- Apr 24, 2025-$430KVZEVP and Group CEO-VZ Business Malady Kyle sold $430,240 worth of shares (10,000 units at $43.02), decreasing direct ownership by 27% to 26,508 unitsForm 4Grant or awardOpen-market sale
- Apr 23, 2025-$212KVZEVP and Group CEO-VZ Business Malady Kyle sold $212,425 worth of shares (5,000 units at $42.48), decreasing direct ownership by 12% to 36,508 unitsForm 4Open-market sale
- Apr 10, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Mar 27, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Mar 18, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Mar 13, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Mar 1, 2025VZEVP and Group CEO-VZ Business Malady Kyle converted options into 52,452 shares, covered exercise/tax liability with 42,858 shares and converted options into 31,914 units of Common StockForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 27, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Feb 13, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Feb 4, 2025-$262KVZEVP and Group CEO-VZ Business Malady Kyle sold $261,623 worth of shares (6,590 units at $39.70), closing all direct ownership in the companyForm 4Open-market sale
- Feb 3, 2025-$319KVZEVP and Group CEO-VZ Business Malady Kyle sold $319,080 worth of shares (8,000 units at $39.88), decreasing direct ownership by 55% to 6,590 unitsForm 4Open-market sale
- Jan 30, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jan 29, 2025-$453KVZEVP and Group CEO-VZ Business Malady Kyle sold $453,155 worth of shares (11,085 units at $40.88), decreasing direct ownership by 43% to 14,590 unitsForm 4Open-market sale
- Jan 28, 2025-$810KVZEVP and Group CEO-VZ Business Malady Kyle sold $809,800 worth of shares (20,000 units at $40.49), decreasing direct ownership by 44% to 25,675 unitsForm 4Open-market sale
- Jan 27, 2025-$811KVZEVP and Group CEO-VZ Business Malady Kyle sold $810,800 worth of shares (20,000 units at $40.54), decreasing direct ownership by 30% to 45,675 unitsForm 4Open-market sale
- Jan 16, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jan 2, 2025VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Dec 19, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Dec 5, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Nov 21, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Oct 24, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Oct 10, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 26, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Sep 12, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Aug 29, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Aug 15, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Aug 1, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 18, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jul 3, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 20, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- Jun 6, 2024VZSEC Form 4 filed by EVP and Group CEO-VZ Business Malady KyleForm 4Grant or award
- May 23, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 22, 2024DXCMMalady Kyle was granted 2,613 shares, increasing direct ownership by 17% to 18,142 unitsForm 4Grant or award
- May 9, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 25, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 11, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 28, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 14, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 1, 2024VZMalady Kyle converted options into 44,960 shares, covered exercise/tax liability with 32,906 shares and converted options into 18,420 units of Common Stock, increasing direct ownership by 87% to 65,675 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 29, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Feb 22, 2024-$979KVZMalady Kyle sold $979,200 worth of shares (24,000 units at $40.80), decreasing direct ownership by 41% to 35,201 unitsForm 4Grant or awardOpen-market sale
- Feb 15, 2024-$605KVZMalady Kyle sold $604,950 worth of shares (15,000 units at $40.33), decreasing direct ownership by 20% to 59,201 unitsForm 4Grant or awardOpen-market sale
- Feb 14, 2024VZMalady Kyle was granted 9,503 shares and covered exercise/tax liability with 3,268 shares, increasing direct ownership by 9% to 74,201 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 1, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 18, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 4, 2024VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 21, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 7, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 21, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 9, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 26, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 12, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 28, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 14, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 31, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or awardDiscretionary plan transaction
- Aug 17, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 3, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 20, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 6, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 22, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 8, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 25, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 18, 2023DXCMSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 11, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 27, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 13, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 30, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 15, 2023-$228KVZSEC Form 4: Malady Kyle sold $228,432 worth of shares (6,226 units at $36.69) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 67,966 unitsForm 4Open-market sale10b5-1 plan
- Mar 14, 2023-$540KVZSEC Form 4: Malady Kyle sold $540,004 worth of shares (14,745 units at $36.62) as part of a pre-agreed trading plan, decreasing direct ownership by 17% to 74,192 unitsForm 4Open-market sale10b5-1 plan
- Feb 23, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Feb 16, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Feb 15, 2023VZSEC Form 4: Malady Kyle covered exercise/tax liability with 19,261 shares and was granted 44,878 shares, increasing direct ownership by 60% to 67,963 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 2, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 19, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 5, 2023VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 22, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 8, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 22, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 9, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 27, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 13, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 29, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 15, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 1, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 18, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 4, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 21, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 7, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 23, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 9, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 26, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 20, 2022DXCMSEC Form 4: Malady Kyle was granted 979 shares, increasing direct ownership by 45% to 3,161 unitsForm 4Grant or award
- May 12, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 28, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 14, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 31, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 17, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 8, 2022VZSEC Form 4: Malady Kyle converted options into 9,419 shares and covered exercise/tax liability with 4,597 shares, increasing direct ownership by 13% to 42,346 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 3, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Mar 2, 2022VZSEC Form 4: Malady Kyle converted options into 11,450 shares and covered exercise/tax liability with 5,588 shares, increasing direct ownership by 19% to 37,524 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2022VZSEC Form 4: Malady Kyle converted options into 13,238 shares and covered exercise/tax liability with 7,365 shares, increasing direct ownership by 23% to 31,662 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Feb 24, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Feb 17, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Feb 3, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 20, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jan 6, 2022VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 22, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Dec 9, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 23, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Nov 11, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 28, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Oct 14, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 30, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 16, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Sep 2, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 19, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Aug 5, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 22, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jul 8, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 24, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Jun 10, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 27, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- May 21, 2021DXCMSEC Form 4: Malady Kyle was granted 910 units of Common Stock, increasing direct ownership by 72% to 2,182 unitsForm 4Grant or award
- May 13, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 29, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 15, 2021VZSEC Form 4 filed by Malady KyleForm 4Grant or award
- Apr 1, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Mar 18, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Mar 8, 2021VZSEC Form 4: Kyle Malady exercised 8,995 units of Common Stock at a strike of $0.00 and disposed of $274,182 worth of Common Stock (4,828 units at $56.79), increasing direct ownership by 19% to 25,789 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 6, 2021VZSEC Form 4: Kyle Malady exercised 4,663 units of Common Stock at a strike of $0.00 and disposed of $133,616 worth of Common Stock (2,386 units at $56.00), increasing direct ownership by 12% to 21,622 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 4, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Mar 2, 2021VZSEC Form 4: Kyle Malady exercised 10,935 units of Common Stock at a strike of $0.00 and disposed of $338,732 worth of Common Stock (6,161 units at $54.98), increasing ownership by 33% to 19,345 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Mar 1, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Feb 25, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Feb 18, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Feb 4, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
- Jan 21, 2021VZSEC Form 4 filed by Kyle MaladyForm 4Grant or award
Compare Kyle Malady with
- Kyle Malady vs Michael Jon Brown1 shared
- Kyle Malady vs Sadie Stern1 shared
- Kyle Malady vs Jereme M Sylvain1 shared
- Kyle Malady vs Jacob Steven Leach1 shared
- Kyle Malady vs Rodriguez Alfonso Villanueva1 shared
- Kyle Malady vs Vandana Venkatesh1 shared
Other insiders at the same companies
- Rodriguez Alfonso VillanuevaVZ
- Vandana VenkateshVZ
- Mary-Lee StillwellVZ
- Anthony T SkiadasVZ
- Joseph J. RussoVZ
- Daniel H SchulmanVZ
- Michael Jon BrownDXCM
- Jacob Steven LeachDXCM
- Jereme M SylvainDXCM
- Sadie SternDXCM
- Euan A. AshleyDXCM
- Christina SchellingVZ
- Phillips Jr Charles EVZ
- Nicholas AugustinosDXCM
- Glenn S BoehnleinDXCM
- Kevin R SayerDXCM
Questions about Kyle Malady
- What is Kyle Malady's role at Verizon Communications Inc?
- Kyle Malady reports to the SEC as EVP and Group CEO-VZ Business at Verizon Communications Inc (VZ), according to the latest filing on November 20, 2026. Kyle Malady has also filed as director at Dexcom Inc (DXCM).
- How many shares does Kyle Malady own?
- After the latest filing that states it, Kyle Malady directly owned 95,566 shares of Verizon Communications Inc (VZ) and 28,242 shares of Dexcom Inc (DXCM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Kyle Malady bought or sold stock recently?
- The most recent open-market sale was on November 17, 2026: sold 1,100 shares of Verizon Communications Inc (VZ) for $50.7K at an average of $46.06.
- How do I get alerts when Kyle Malady files?
- Follow Kyle Malady on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Kyle Malady filed 14 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Kyle Malady (SEC CIK 0001760581). Totals count each trade once, skipping amendments whose original is on file, from Jan 25, 2021 on. View on SEC EDGAR · Get this as JSON